Rxo (RXO) Non-Current Debt (2022 - 2026)

Rxo (RXO) has reported Non-Current Debt for 5 consecutive years, with $430.0 million the latest figure, recorded in Q1 2026.

• Non-Current Debt for Q1 2026 came in at $430.0 million, up 11.11% year-over-year; the trailing twelve-month figure through Mar 2026 was $430.0 million (up 11.11% YoY), and the FY2025 annual result was $387.0 million, up 10.26% from the prior year.
• Non-Current Debt was $430.0 million for Q1 2026 at Rxo, up from $387.0 million in the prior quarter.
• Over five years, Non-Current Debt peaked at $451.0 million in Q4 2022 and troughed at $6.0 million in Q3 2022.
• Average Non-Current Debt over 5 years is $371.2 million, with a median of $387.0 million recorded in 2025.
• Year-over-year, Non-Current Debt soared 7416.67% in 2023 and decreased 22.17% in 2024.
• Over 5 years, Non-Current Debt stood at $451.0 million in 2022, then fell by 21.06% to $356.0 million in 2023, then decreased by 1.4% to $351.0 million in 2024, then grew by 10.26% to $387.0 million in 2025, then climbed by 11.11% to $430.0 million in 2026.
• Per Business Quant data, the three most recent Non-Current Debt figures were $430.0 million in Q1 2026, $387.0 million in Q4 2025, and $387.0 million in Q3 2025.